4//SEC Filing
Kordasiewicz Holly B. 4
Accession 0000874015-26-000067
CIK 0000874015other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 8:18 PM ET
Size
14.0 KB
Accession
0000874015-26-000067
Insider Transaction Report
Form 4
Kordasiewicz Holly B.
EVP, Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-15+11,119→ 18,859 total - Sale
Common Stock
[F2][F3]2026-01-16$75.66/sh−4,141$313,308→ 14,718 total - Exercise/Conversion
Restricted Stock Unit
[F4][F5]2026-01-15−11,119→ 20,830 totalExercise: $0.00From: 2026-01-15→ Common Stock (11,119 underlying) - Award
Restricted Stock Unit
[F6][F4][F5]2026-01-15+13,650→ 34,480 totalExercise: $0.00From: 2027-01-15→ Common Stock (13,650 underlying) - Award
Restricted Stock Unit
[F6][F4][F5]2026-01-15+11,250→ 45,730 totalExercise: $0.00From: 2027-01-15→ Common Stock (11,250 underlying)
Footnotes (6)
- [F1]Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards.
- [F2]The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.63 to $75.72 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
- [F4]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F5]Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
- [F6]Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Holly Kordasiewicz|2026-01-20
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0002102721
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 8:18 PM ET
- Size
- 14.0 KB